| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director
2 companies
Cherington Charles is a 10% Owner at Ernexa Therapeutics Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 9 buys and 3 sells.
Estimated insider holdings value: $258.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | ERNAW Ernexa Therapeutics Inc. | 10% Owner | Buy | 4,000,000 | $0.50 | $2,000,000.00 | +143.9% | - | - | |
| Jun 9, 2025 | ERNA Ernexa Therapeutics Inc. | 10% Owner | Buy | 21,241,163 | $0.10 | $2,221,825.65 | +104.0% | -56.3% | +139.9% | |
| Apr 2, 2025 | ERNA Ernexa Therapeutics Inc. | 10% Owner | Buy | 3,768,397 | $0.10 | $394,174.33 | +22.7% | -36.5% | -93.0% | |
| Oct 29, 2024 | ERNA Ernexa Therapeutics Inc. | 10% Owner | Buy | 13,252,112 | $0.00 | - | +50.9% | -60.0% | -89.3% | |
| Dec 2, 2022 | ERNA Ernexa Therapeutics Inc. | Director, 10% Owner | Buy | 261,756 | $3.28 | $858,559.68 | +88.8% | +13.6% | -63.0% | |
| Jun 17, 2021 | ERNA Ernexa Therapeutics Inc. | Director, 10% Owner | Sell | 400,000 | $15.74 | $6,296,567.80 | -2.2% | -20.2% | -96.8% |